ESSA Pharma Inc.: Istoricul versiunilor

21 septembrie 2024

• actualăprec 15:4221 septembrie 2024 15:42‎ 127.0.0.1 discuție‎ 973 de octeți +27‎ The LinkTitles extension automatically added links to existing pages (https://github.com/bovender/LinkTitles). anulare

18 septembrie 2024

• actualăprec 13:5618 septembrie 2024 13:56‎ Admin discuție contribuții‎ 946 de octeți +946‎ Pagină nouă: Pagina dedicata companiei ESSA Pharma Inc. listata cu simbolul CA.EPI ==Descriere companie== ESSA Pharma Inc. (www.essapharma.com) is a Canada-based clinical-stage pharmaceutical company. The Company is focused on developing therapies for the treatment of prostate cancer. The Company’s lead candidate, EPI-7386 is an oral, small molecule that inhibits the androgen receptor (AR) through a novel mechanism of action (N-terminal domain inhibition). The Company is evaluating EPI...